Medication info
Empavia Tablet 25/5 mg (Empagliflozin, Linagliptin)

Empavia Tablet 25/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin Amorphous›25mg / 1 tabletLinagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
Aprogen Pharmaceuticals, Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets/box [14 tablets/PTP x 2], 30 tablets/bottle
Approval status
Active

MFDS item code 202500417 · Approved 2025.02.26 · Insurance code 645211050

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose may be increased to 25/5 mg once daily. Patients switching to this drug from concomitant therapy with empagliflozin and linagliptin should receive the same doses they were previously taking. This drug may be taken with or without food. Swallow the tablet whole. If a dose is missed, take it as soon as remembered. However, if it is within 12 hours of the next scheduled dose, skip the missed dose and take the next dose at the usual time. Do not take a double dose in one day. Patients with renal impairment This drug is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older.

Ingredients

Manufacturer
Aprogen Pharmaceuticals, Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used as an adjunct to diet and exercise to improve blood glucose control in patients with type 2 diabetes who are appropriate for combination therapy with empagliflozin and linagliptin. In other words, it helps patients with type 2 diabetes manage their blood glucose more effectively.

How to take

Adult dose

The recommended starting dose of this drug is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose may be increased to 25/5 mg once daily. Patients switching to this drug from concomitant therapy with empagliflozin and linagliptin should receive the same doses they were previously taking. This drug may be taken with or without food. Swallow the tablet whole. If a dose is missed, take it as soon as remembered. However, if it is within 12 hours of the next scheduled dose, skip the missed dose and take the next dose at the usual time. Do not take a double dose in one day. Patients with renal impairment This drug is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Older adults No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older.

Precautions

This medication should not be used in certain patients. For example, patients who are allergic to any of the active or inactive ingredients of this medication, patients with type 1 diabetes, patients with diabetic ketoacidosis, patients undergoing dialysis, and patients with a history of myocardial infarction should not take this medication. Patients with renal impairment may experience reduced efficacy of this medication, therefore it is important to routinely monitor renal function before and during treatment. Additionally, caution should be exercised when administering to patients in NYHA functional classification I-II stage of heart failure, and it is not recommended for patients in more severe stages. Rare side effects such as acute pancreatitis or blistering similar to pemphigus may occur during the use of this medication, so if persistent abdominal pain or skin blisters develop, consult a physician immediately. The most common side effects include urinary tract infections, and occasionally reports of hypoglycemia, ketoacidosis, pancreatitis, and allergic reactions have been made. Extra caution is needed, especially when taken with insulin or sulfonylureas, as the risk of hypoglycemia may increase. This medication may lower blood pressure due to decreased fluid volume; therefore, it should be used carefully in patients with hypotension or cardiovascular disease, as well as in elderly patients. The risk of urinary tract infections and genital fungal infections may also increase, and if symptoms of infection appear, immediate treatment should be sought. It is advisable for pregnant or breastfeeding women to avoid using this medication, and it is not recommended for children under 18 years of age due to insufficient evidence of safety and efficacy. In cases of overdose, there are no specific antidotes, so appropriate treatment should be based on the symptoms, and this medication is unlikely to be removed by hemodialysis. This medication may slightly affect the ability to drive or operate machinery, especially when taken with drugs that carry a risk of hypoglycemia; caution should be exercised in such cases. Finally, when storing this medication, keep it out of reach of children, and store it in its original container to maintain quality.

Side effects

  • Urinary tract infection
  • vulvovaginitis
  • vulvitis
  • balanitis
  • genital infection
  • hypersensitivity
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 187 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcer formation
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • blood volume depletion
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased red blood cell volume
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • upper abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • septicemia
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorder
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial edema
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • stomach cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina pectoris
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • constipation
  • upper abdominal pain
  • indigestion
  • vomiting
  • gastroesophageal reflux disease
  • gastritis
  • nausea
  • diarrhea
  • headache
  • drowsiness
  • chest discomfort
  • weakness
  • nosebleed
  • oropharyngeal pain
  • vocal cord dysfunction
  • allergic rhinitis
  • exercise-induced dyspnea
  • wet cough
  • runny nose
  • dermatitis
  • male pattern hair loss
  • hyperhidrosis
  • hair loss
  • anxiety
  • depression
  • insomnia
  • hypertension
  • ear pain
  • positional vertigo
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • obesity
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • circular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurry vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival hyperemia
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • serous retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • activity-related dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • rib fracture
  • long ligament syndrome
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular pathology
  • peripheral artery occlusive disease
  • unstable angina
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • ear pain
  • dizziness
  • anemia
  • lymphadenopathy
  • goiter
  • diarrhea
  • indigestion
  • abdominal pain
  • nausea
  • gastritis
  • gastrointestinal dysfunction
  • dizziness
  • headache
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • hyperglycemia
  • back pain
  • cough
  • dyspnea
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is also advisable to keep it at room temperature, between 1 to 30 degrees Celsius, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets/box [14 tablets/PTP x 2], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.